Feature Channels: Blood

Filters close
Newswise: ASH: Targeted oral therapy reduced disease burden and improved symptoms for patients with rare blood disorder
8-Dec-2023 11:00 AM EST
ASH: Targeted oral therapy reduced disease burden and improved symptoms for patients with rare blood disorder
University of Texas MD Anderson Cancer Center

The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with a rare blood disorder called nonadvanced system mastocytosis.

Newswise: elias_jabbour.jpg.resize.405.575.high.jpg
8-Dec-2023 1:15 PM EST
ASH: Novel menin inhibitors show promise for patients with advanced acute myeloid leukemias
University of Texas MD Anderson Cancer Center

Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the treatment of relapsed or refractory acute leukemias with specific genetic alterations.

Released: 8-Dec-2023 4:05 PM EST
La explicación científica detrás de algunas reacciones extrañas del cuerpo
Mayo Clinic

A diario, el cuerpo hace algunas cosas bastante extrañas e inusuales. A continuación, se incluyen algunas preguntas y respuestas que ofrecen la explicación científica de por qué suceden.

   
Released: 8-Dec-2023 3:05 PM EST
A explicação científica para reações peculiares do organismo
Mayo Clinic

Todos os dias, nossos organismos reagem de formas peculiares e incomuns. Aqui estão algumas perguntas e respostas que explicam a base científica desses eventos.

Newswise: NIH diversity grant to fund student’s 3D bioprinting research
Released: 7-Dec-2023 12:05 PM EST
NIH diversity grant to fund student’s 3D bioprinting research
Penn State Materials Research Institute

Bioprinted, lab-grown networks of blood vessels in tissue could advance research on a variety of vascular diseases that affect millions of people worldwide, according to Angie Castro, a doctoral student pursuing a degree in chemical engineering at Penn State.

Newswise: New Case Western Reserve University study finds diabetes drug may reduce risk for colorectal cancer
5-Dec-2023 11:05 AM EST
New Case Western Reserve University study finds diabetes drug may reduce risk for colorectal cancer
Case Western Reserve University

A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).

Released: 7-Dec-2023 10:05 AM EST
Use of anticoagulant drug after aortic valve replacement lowers mortality risk, Mayo Clinic study finds
Mayo Clinic

Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of blood clots, according to a retrospective study published in Mayo Clinic Proceedings.

Released: 6-Dec-2023 6:05 PM EST
Stanford Medicine-led study finds way to predict which of our organs will fail first
Stanford Medicine

Like any typical car or house or society, the pace at which parts of our bodies fall apart varies from part to part.

Released: 6-Dec-2023 2:05 PM EST
New study finds many couples around the world may share high blood pressure
American Heart Association (AHA)

A study of married or partnered, middle-aged and older heterosexual couples in the U.S., England, China and India found that in 20% to 47% of the couples, both spouses/partners had high blood pressure.

Not for public release

This news release is embargoed until 6-Dec-2023 1:00 PM EST Released to reporters: 6-Dec-2023 1:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 6-Dec-2023 1:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: New Research Sheds Light on Equitable Treatment Options for Pediatric Patients with Sickle Cell Disease
Released: 6-Dec-2023 12:05 PM EST
New Research Sheds Light on Equitable Treatment Options for Pediatric Patients with Sickle Cell Disease
Yale Cancer Center/Smilow Cancer Hospital

Patients with sickle cell disease (SCD) often face a reduced quality of life and a lower life expectancy. Allotransplantation, the first treatment for SCD with curative potential, comes with risks, including transplant-related mortality. Gene therapy, once approved for SCD, could also offer a lifelong cure without the risk associated with allotransplantation.

Released: 6-Dec-2023 10:00 AM EST
MD Anderson Research Highlights: ASH 2023 Special Edition
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Newswise: Small but mighty: Microparticles from the placenta may offer major clues on the in utero development of neurobehavioral disorders
Released: 6-Dec-2023 7:05 AM EST
Small but mighty: Microparticles from the placenta may offer major clues on the in utero development of neurobehavioral disorders
University of Missouri, Columbia

For 30 years, Cheryl Rosenfeld has studied how biological information gets transferred from mothers to babies during pregnancy.

Released: 5-Dec-2023 7:05 AM EST
Both virtual and in-person nutrition visits help to lower cholesterol, study finds
Michigan Medicine - University of Michigan

Telemedicine visits for patients with hyperlipidemia — an excess of cholesterol or fats in the blood — experienced similar positive health benefits compared to those who had in-person visits, a study finds. Researchers say telemedicine offers additional options to access treatment that could reduce the risk of cardiovascular disease.

Released: 4-Dec-2023 6:05 PM EST
Lipids and diabetes are closely linked
Université de Genève (University of Geneva)

While sugar is the most frequently named culprit in the development of type 2 diabetes, a better understanding of the role of fats is also essential.

Newswise: Leukemia cells activate cellular recycling program
Released: 4-Dec-2023 5:05 PM EST
Leukemia cells activate cellular recycling program
Goethe University Frankfurt

In a recent study, scientists led by Professor Stefan Müller from Goethe University’s Institute of Biochemistry II investigated a specific form of blood cancer known as acute myeloid leukemia, or AML. The disease mainly occurs in adulthood and often ends up being fatal for older patients.

Not for public release

This news release is embargoed until 4-Dec-2023 5:00 PM EST Released to reporters: 28-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 4-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

4-Dec-2023 8:00 AM EST
MD Anderson’s Katy Rezvani, M.D., receives 2023 Honorific Award from the American Society of Hematology
University of Texas MD Anderson Cancer Center

Katy Rezvani, M.D., Ph.D., professor of Stem Cell Transplantation & Cellular Therapy at The University of Texas MD Anderson Cancer Center, has been honored with the E. Donnall Thomas Lecture and Prize from the American Society of Hematology (ASH, for her groundbreaking research to develop and advance innovative cell therapies for cancer using natural killer (NK) cells.

Newswise: Promising Phase III Results Give Hope to Patients with Myelodysplastic Syndromes
Released: 4-Dec-2023 9:30 AM EST
Promising Phase III Results Give Hope to Patients with Myelodysplastic Syndromes
Yale Cancer Center/Smilow Cancer Hospital

Based on the results from this phase III trial, Yale Cancer Center expert Dr. Amer Zeidan says imetelstat, a first-in-class telomerase inhibitor, leads to durable red blood cell transfusion independence and a significant improvement in anemia in heavily transfused lower risk MDS patients.

Newswise: YTHDF2's Role in Promoting Acute Myeloid Leukemia: The Key Lies in microRNA Processing
Released: 4-Dec-2023 8:45 AM EST
YTHDF2's Role in Promoting Acute Myeloid Leukemia: The Key Lies in microRNA Processing
Chinese Academy of Sciences

Gene expression is often regulated by chemical modifications, a process known as epigenetics for DNA and epitranscriptomics for RNA. Among these, N6-methyladenosine (m6A) is a significant internal modification of mRNA that plays crucial roles in gene expression and various biological and pathological processes, including cancer development.

Released: 30-Nov-2023 3:40 PM EST
Prenatal Stem Cells Treat Hemophilia A
Wake Forest Institute for Regenerative Medicine

Researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently published an article in Nature Communications that demonstrates the potential of bioengineered human placental cells as a cure for Hemophilia A.

Released: 30-Nov-2023 2:05 PM EST
Fred Hutch at ASH: Gene therapies for sickle cell, how to improve ‘time toxicity’ for multiple myeloma treatments, what makes a ‘perfect’ graft — and much more
Fred Hutchinson Cancer Center

SEATTLE — Nov. 30, 2023 — The 65th Annual Meeting & Exposition of the American Society of Hematology (ASH) will take place in San Diego, Calif. and online Dec. 9-13.Below are highlights of Fred Hutchinson Cancer Center research to be presented and experts available to comment on news.

Newswise: GLADWIN285A.jpg
Released: 29-Nov-2023 1:05 PM EST
University of Maryland School of Medicine Dean Mark T. Gladwin Leads International Randomized Clinical Trials for Novel Sickle Cell Treatment
University of Maryland School of Medicine

University of Maryland School of Medicine Dean Mark T. Gladwin, MD will join prominent scientists and government health officials this week at a Symposium in Rio De Janeiro, Brazil, to discuss new treatments for sickle cell disease (SCD).

Newswise: Memorial Sloan Kettering Cancer Center and NMDP/Be The Match Launch “American Symphony: Become a Lifesaver” Campaign
28-Nov-2023 4:05 PM EST
Memorial Sloan Kettering Cancer Center and NMDP/Be The Match Launch “American Symphony: Become a Lifesaver” Campaign
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) and NMDP/Be The Match® today announced the launch of the “American Symphony: Become a Lifesaver” campaign to increase registration of blood stem cell and marrow donors to the national registry and improve access to blood stem cell transplants.

Newswise: RUDN Scientists on the Possibilities of Studying Single Cells in One of the Types of Childhood Leukemia
Released: 29-Nov-2023 3:05 AM EST
RUDN Scientists on the Possibilities of Studying Single Cells in One of the Types of Childhood Leukemia
Scientific Project Lomonosov

RUDN Laboratory of Biology of Single Cells studied the possibilities of DNA sequencing at the level of individual cells in patients with a rare form of childhood leukemia.

Newswise: Yale Cancer Center Experts Present New Research at Hematology Annual Meeting
Released: 28-Nov-2023 4:05 PM EST
Yale Cancer Center Experts Present New Research at Hematology Annual Meeting
Yale Cancer Center/Smilow Cancer Hospital

Physicians and scientists from Yale Cancer Center, part of Yale School of Medicine, will present new research at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, Calif., from December 9 to 12. This year’s ASH meeting will include oral and poster presentations, workshops, and educational sessions for hematology professionals.

28-Nov-2023 11:30 AM EST
Ohio State receives $14 million to study optimal aspirin therapy in pregnancy
Ohio State University Wexner Medical Center

A research team at The Ohio State University Wexner Medical Center and College of Medicine has been approved for a $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people.

Newswise: St. Jude revealed functional targets of oncogenic HOXA9 in high-risk pediatric leukemia
Released: 28-Nov-2023 11:05 AM EST
St. Jude revealed functional targets of oncogenic HOXA9 in high-risk pediatric leukemia
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital identified target genes bound and regulated by HOXA9, a protein overexpressed in high-risk leukemia, extending understanding and opening new possibilities for treatment.

Newswise: Montefiore Einstein Comprehensive Cancer Center Awarded FDA Grant for Clinical Trial on Experimental AML/MDS Treatment
Released: 28-Nov-2023 10:00 AM EST
Montefiore Einstein Comprehensive Cancer Center Awarded FDA Grant for Clinical Trial on Experimental AML/MDS Treatment
Montefiore Einstein Comprehensive Cancer Center

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)—two related blood diseases that disproportionally strike older adults—are notoriously difficult to treat and associated with high relapse rates.

Released: 27-Nov-2023 6:05 PM EST
Cellular postal service delivers messages from non-human cells, too
University of Connecticut

Messenger bubbles produced by human cells can pick up bacterial products and deliver them to other cells, University of Connecticut researchers report in the Nov. 16 issue of Nature Cell Biology.

   

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 22-Nov-2023 6:05 PM EST
Cancer blood tests jumpstart diagnoses and targeted therapy
UC Davis Health

DNA fragments circulating in patients’ blood can reveal the presence of tumors long before CT scans and lead to more agile use of cancer drugs.

Newswise: Lowering a form of brain cholesterol reduces Alzheimer’s-like damage in mice
20-Nov-2023 10:05 AM EST
Lowering a form of brain cholesterol reduces Alzheimer’s-like damage in mice
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have found that a form of cholesterol known as cholesteryl esters builds up in the brains of mice with Alzheimer’s-like disease, and that clearing out the cholesteryl esters helps prevent brain damage and behavioral changes.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Newswise: Written in Blood
16-Nov-2023 10:05 AM EST
Written in Blood
American Institute of Physics (AIP)

In Physics of Fluids, scientists demonstrate how bloodstains can yield valuable details by examining the protrusions that deviate from the boundaries of otherwise elliptical bloodstains. The researchers studied how these “tails” are formed using a series of high-speed experiments with human blood droplets less than a millimeter wide impacting horizontal surfaces at various angles. They found that the tail length can reflect information about the size, impact speed, and impact angle of the blood drop that formed the stain.

Newswise: Type 2 diabetes: a new disease mechanism uncovered
Released: 21-Nov-2023 8:05 AM EST
Type 2 diabetes: a new disease mechanism uncovered
Universite de Montreal

Published just before World Diabetes Day, work by Dr. May Faraj, director of the Research Unit on Nutrition, Lipoproteins and Cardiometabolic Diseases at the Montreal Clinical Research Institute (IRCM) and full professor at the Department of Nutrition at the University of Montreal, highlight a new mechanism and a new role for LDL – commonly called bad cholesterol – in the development of type 2 diabetes, LDL already being involved in cardiovascular diseases in the human.

Released: 20-Nov-2023 2:05 PM EST
UC Irvine-led study is first to find brain hemorrhage cause other than injured blood vessels
University of California, Irvine

Irvine, Calif., Nov. 20, 2023 — A first-of-its-kind study led by the University of California, Irvine has revealed a new culprit in the formation of brain hemorrhages that does not involve injury to the blood vessels, as previously believed. Researchers discovered that interactions between aged red blood cells and brain capillaries can lead to cerebral microbleeds, offering deeper insights into how they occur and identifying potential new therapeutic targets for treatment and prevention.

Released: 17-Nov-2023 1:05 PM EST
Discovery of hemoglobin in the epidermis sheds new light on our skin's protective properties
Elsevier

Research published in the Journal of Investigative Dermatology provides important insights into skin's defense mechanism against aging and cancer

Newswise: Fusion oncoprotein forces cell fates toward rhabdomyosarcoma
Released: 15-Nov-2023 12:05 PM EST
Fusion oncoprotein forces cell fates toward rhabdomyosarcoma
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital showed that a fusion oncoprotein can drive molecularly indistinguishable rhabdomyosarcomas arising from both muscle and blood vessel cells.

Newswise: National Film Festival Debuts Documentary About First-of-Its-Kind Blood Cancer Master Clinical Trial
Released: 15-Nov-2023 8:05 AM EST
National Film Festival Debuts Documentary About First-of-Its-Kind Blood Cancer Master Clinical Trial
The Leukemia & Lymphoma Society (LLS)

The story of a clinical trial that is unlocking a new, personalized treatment approach with the power to save the lives of thousands of people living with an aggressive and deadly form of leukemia was screened at the American Public Health Association Film Festival this week.

Released: 15-Nov-2023 3:05 AM EST
Another step toward the HIV-1 vaccine: Dynamics of neutralizing antibodies
University of Cologne

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these antibodies in vaccinated humans.

Released: 13-Nov-2023 7:05 PM EST
New assay could revolutionize detection and treatment of acute myeloid leukemia
Elsevier

A novel assay that detects a unique molecular marker in patients with acute myeloid leukemia (AML) may revolutionize the way this disease is detected and treated according to a new report in The Journal of Molecular Diagnostics published by Elsevier.

Released: 13-Nov-2023 3:05 PM EST
Ground-breaking discovery could pave the way for new therapies to prevent cardiovascular disease and stroke
University of Leicester

Researchers at the University of Leicester have discovered the mechanism by which cholesterol in our diet is absorbed into our cells

11-Nov-2023 10:10 AM EST
Transfusing More Blood May Benefit Patients Who Have Had Heart Attack and Have Anemia
Rutgers University-New Brunswick

An international clinical trial led by physician Jeffrey L. Carson, distinguished professor of medicine at Rutgers Robert Wood Johnson Medical School, found that a liberal blood transfusion given to patients who have had a heart attack and have anemia may reduce the risk of a reoccurrence and improve survival rates.

Newswise: UTHealth Houston researchers awarded $2.6M NIH grant to study molecular pathways and potential strategies for treatment of myocardial ischemia and reperfusion injury
Released: 9-Nov-2023 4:05 PM EST
UTHealth Houston researchers awarded $2.6M NIH grant to study molecular pathways and potential strategies for treatment of myocardial ischemia and reperfusion injury
University of Texas Health Science Center at Houston

A four-year, $2.6 million grant to study circadian rhythm and novel therapies to protect the heart during a heart attack or cardiac surgery has been awarded to UTHealth Houston by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

8-Nov-2023 4:05 PM EST
Sylvester research shows how interactions between tumor genes and microenvironment influence treatment response in multiple myeloma
Sylvester Comprehensive Cancer Center

A multicenter study led by researchers at Sylvester Comprehensive Cancer Center shows how interactions between tumor cells and immune components of the microenvironment can impact treatment responses and outcomes in patients newly diagnosed with multiple myeloma who undergo combination treatments that include targeted immunotherapy.

Newswise: S&T professor’s glass powder that controls bleeding may also prevent infections
Released: 8-Nov-2023 3:05 PM EST
S&T professor’s glass powder that controls bleeding may also prevent infections
Missouri University of Science and Technology

Scientist to collaborate with South African researcher to test glass powder for antibacterial properties.

   
Released: 8-Nov-2023 2:05 PM EST
Jana Care, Inc. Announces Initial Closing of a $6 Million Financing Round to Complete Commercialization of its Self-administered Blood Tests for Kidney and Heart Disease
Jana Care

Jana Care has secured funding to expand its at-home testing platform for chronic kidney and heart disease management.



close
1.53467